Viet Reader.

VR.

Premier Newspaper for Vietnamese Worldwide

Theratechnologies to Announce Fourth Quarter and Full Year

MONTREAL, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will report financial results for its fourth quarter and full year fiscal 2022 ended November 30, on Tuesday, February 28, 2023.

The conference call will be held at 8:30 a.m. (ET) on February 28, 2023, to discuss the results and recent business updates. The call will be hosted by Paul Levesque, President and Chief Executive Officer. Joining Mr. Levesque on the call will be other members of the management team, including Chief Financial Officer Philippe Dubuc, Chief Medical Officer Christian Marsolais, and Chief Commercial Officer John Leasure, who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least ten minutes in advance to secure access.

Conference call dial-in and replay information is below:

CONFERENCE CALL INFORMATION
Conference Call Date:February 28, 2023
Conference Call Time:8:30 AM ET
North America Dial-in:1- 877-513-4119
International Dial-in:1- 412-902-6615
Access Code:2102918
CONFERENCE CALL REPLAY
North America Dial-in:1- 877-344-7529
International Dial-in:1- 412-317-0088
Replay Access Code: 3648244
Replay End DateMarch 07, 2023


The live conference call will be accessible via webcast at:
https://edge.media-server.com/mmc/p/urf63wqf

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

Investor Inquiries:
Elif McDonald
Senior Director, Investor Relations
ir@theratech.com
1-438-315-8563

Media Inquiries:
Julie Schneiderman
Senior Director, Communications and Corporate Affaires
communications@theratech.com
1 514 336-7800


Theratechnologies to Announce Fourth Quarter and Full Year

About author
You should write because you love the shape of stories and sentences and the creation of different words on a page.
View all posts